alakonteksin

Alakonteksin is a small, water-soluble protein that belongs to the family of S100 proteins. It is primarily expressed in the brain and plays a role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Alakonteksin is encoded by the ALK gene, which is located on chromosome 17q21.3.

The protein is composed of 96 amino acids and has a molecular weight of approximately 11 kDa. It is characterized by its ability to bind to calcium ions, which is a common feature among S100 proteins. Alakonteksin has been shown to interact with several other proteins, including actin, tubulin, and various kinases, suggesting its involvement in cytoskeletal dynamics and signal transduction.

Alakonteksin has been implicated in several neurological disorders. Its expression is altered in various brain regions in models of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and Huntington's disease. Additionally, alakonteksin has been found to be involved in the pathogenesis of epilepsy and schizophrenia.

The exact mechanisms by which alakonteksin contributes to these disorders are not fully understood, but ongoing research aims to elucidate its role in these complex diseases. Future studies may provide insights into potential therapeutic targets for neurological disorders.